Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig T Jordan

Showing results (101-110 of 164) with videos related to

Pageof 17
Sort By:
Blood|September 15, 2021
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylationMaria L Amaya, Anagha Inguva, Shanshan Pei, et al.
Frontiers in Pharmacology|February 15, 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML PatientTorsten H Nielsen, Nathalie Johnson, Nicolas Garnier, et al.
Blood Advances|April 21, 2020
Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progressionZachary J Walker, Michael J VanWyngarden, Brett M Stevens, et al.
Blood|January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic targetSaman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the scienceMitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Molecular Cancer Therapeutics|June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemiaMonica L Guzman, Neng Yang, Krishan K Sharma, et al.
Journal of Leukocyte Biology|November 6, 2020
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cellsDaniel A Pollyea, Hyun Min Kim, Brett M Stevens, et al.
Cell Stem Cell|July 5, 2016
Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue NicheHaobin Ye, Biniam Adane, Nabilah Khan, et al.
Haematologica|December 18, 2023
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidineAmanda C Winters, Mohd Minhajuddin, Brett M Stevens, et al.
Leukemia & Lymphoma|September 22, 2015
Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution seriesBrett Stevens, Julia Maxson, Jeffrey Tyner, et al.
Pageof 17

Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Blood|September 15, 2021
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylationMaria L Amaya, Anagha Inguva, Shanshan Pei, et al.
Frontiers in Pharmacology|February 15, 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML PatientTorsten H Nielsen, Nathalie Johnson, Nicolas Garnier, et al.
Blood Advances|April 21, 2020
Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progressionZachary J Walker, Michael J VanWyngarden, Brett M Stevens, et al.
Blood|January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic targetSaman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the scienceMitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Molecular Cancer Therapeutics|June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemiaMonica L Guzman, Neng Yang, Krishan K Sharma, et al.
Journal of Leukocyte Biology|November 6, 2020
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cellsDaniel A Pollyea, Hyun Min Kim, Brett M Stevens, et al.
Cell Stem Cell|July 5, 2016
Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue NicheHaobin Ye, Biniam Adane, Nabilah Khan, et al.
Haematologica|December 18, 2023
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidineAmanda C Winters, Mohd Minhajuddin, Brett M Stevens, et al.
Leukemia & Lymphoma|September 22, 2015
Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution seriesBrett Stevens, Julia Maxson, Jeffrey Tyner, et al.
Pageof 17